Business Wire

Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its nAAVigation™ Vector Platform (nAAVigation). Leveraging decades of Adeno ...
FiercePharma

Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year

Charles River in March paid $875 million for plasmid and cell therapy CDMO Cognate BioServices. ( efetova/iStock/Getty Images Plus/Getty Images) A few short months after Charles River Laboratories ...
Business Wire

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

ROCKVILLE, Md.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral ...
FiercePharma

Charles River inks viral vector production pact for Navega's chronic pain gene therapy

Charles River will help bring NT-Z001 to the clinic by leveraging its off-the-shelf plasmid products, custom plasmid capabilities and adeno-associated virus (AAV) production. (Getty Images) After ...